Disease-modifying drugs for multiple sclerosis and subsequent health service use

OBJECTIVE: We assessed the relationship between the multiple sclerosis (MS) disease-modifying drugs (DMDs) and healthcare use. METHODS: Persons with MS (aged ⩾18 years) were identified using linked population-based health administrative data in four Canadian provinces and were followed from the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Huah Shin, Zhu, Feng, Kingwell, Elaine, Zhao, Yinshan, Yao, Shenzhen, Ekuma, Okechukwu, Svenson, Lawrence W, Evans, Charity, Fisk, John D, Marrie, Ruth Ann, Tremlett, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958569/
https://www.ncbi.nlm.nih.gov/pubmed/34949130
http://dx.doi.org/10.1177/13524585211063403

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8958569/
https://www.ncbi.nlm.nih.gov/pubmed/34949130
http://dx.doi.org/10.1177/13524585211063403

Ejemplares similares